Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 43, Issue 2 (Apr 2005)

Issues

Integration between point-of-care cardiac markers in an emergency/cardiology department and the central laboratory: methodological and preliminary clinical evaluation

Francesca Di Serio / Gianfranco Amodio / Lucia Varraso / Maurizio Campaniello / Paola Coluccia / Paolo Trerotoli / Gianfranco Antonelli / Nicola Pansini
Published Online: 2011-09-21 | DOI: https://doi.org/10.1515/CCLM.2005.035

Abstract

To achieve rapid assessment of chest pain in emergency/cardiology departments, a short turnaround time for cardiac marker testing is necessary. Nevertheless, Total Quality Management principles must be incorporated into the management of point-of-care testing (POCT); in this setting we implemented the Stratus CS ® assay as POCT for cardiac markers in our emergency/cardiology department. The analytical performance of the troponin I method was evaluated; information connectivity between the Stratus CS ® data management system and the laboratory information system was implemented and practical training of testing personnel was carried out at the POCT site. A total of 41 non-ST-segment elevation patients admitted to the hospital were followed to evaluate the appropriateness of hospital admission, formulated on the basis of the cardiac troponin-I level measured at the POCT site by clinical staff. Our preliminary clinical data suggest that the high sensitivity of the Stratus CS ® troponin method could play an important role in the early identification of patients with acute myocardial infarction in a low to intermediate-risk population for acute coronary syndrome. Our POCT model suggests that the central laboratory could ensure that the POCT program remains in compliance with quality requirements. Nevertheless, our comparison studies suggest that the implementation of POCT requires a high level of integration between cardiologists and pathologists to guarantee appropriate interpretation of the monitoring results for suspected ACS patients.

Keywords: acute myocardial infarction (AMI); emergency department; point-of-care testing (POCT); troponin I

References

  • 1

    Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined – a Consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000; 36: 959–69. Eur Heart J 2000;21:1502–13. CrossrefGoogle Scholar

  • 2

    Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation 2000; 102: 1193–209. Google Scholar

  • 3

    Panteghini M, Apple FS, Christenson RH, Dati F, Mair J, Wu AH. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. Use of biochemical markers in acute coronary syndromes. Clin Chem Lab Med 1999; 37: 687–93. CrossrefGoogle Scholar

  • 4

    Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes RJ. National Academy of Clinical Biochemistry standards of laboratory practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999; 45: 1104–21. Google Scholar

  • 5

    Di Serio F, Antonelli G, Trerotoli P, Tampoia M, Matarrese M, Pansini N. Appropriateness of point-of-care testing (POCT) in an emergency department. Clin Chim Acta 2003; 333: 185–9. CrossrefGoogle Scholar

  • 6

    Public Health Service Act. S353, 42 USC S263a, 1988. Google Scholar

  • 7

    US Department of Health and Human Services. Medicare, Medicaid and CLIA programs: regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Final rule. Fed Reg 1993; 58:5215–37. Google Scholar

  • 8

    National Committee for Clinical Laboratory Standards. Point-of-care in vitro diagnostic (IVD) testing; approved guideline. NCCLS guideline AST2-A. Wayne, PA: NCCLS, June 1999. Google Scholar

  • 9

    Hudson MP, Christenson RH, Newby LH, Kaplan AL, Ohman EG. Cardiac markers: point of care testing. Clin Chim Acta 1999; 284: 223–37. CrossrefGoogle Scholar

  • 10

    Panteghini M, Gerhardt W, Apple FS, Dati F, Ravkilde J, Wu AH. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). IFCC Scientific Division Committee on Standardization of Markers of Cardiac Damage. Quality specifications for cardiac troponin assays. Clin Chem Lab Med 2001; 39: 174–8. Google Scholar

  • 11

    Panteghini M. The measurement of cardiac markers. Where should we focus? Am J Clin Pathol 2002; 118: 354–61. CrossrefGoogle Scholar

  • 12

    Wu AHB. Point-of-care testing for cardiac markers. Point Care 2002; 1: 39–41. Web of ScienceGoogle Scholar

  • 13

    Singh P, Moll F, Lin SH, Ferzli C, Yu KS, Koski RK, et al. Starburst™ dendrimers: enhanced performance and flexibility for immunoassays. Clin Chem 1994; 40: 1845–9. Google Scholar

  • 14

    Heeschen C, Goldmann BU, Langenbrink L, Matschuck G, Hamm CW. Evaluation of a rapid whole blood ELISA for quantification of troponin I in patients with acute chest pain. Clin Chem 1999; 45: 1789–96. Google Scholar

  • 15

    Altinier S, Mion M, Cappelletti A, Zaninotto M, Plebani M. Rapid measurement of cardiac markers on Stratus CS. Clin Chem 2000; 46: 991–3. Google Scholar

  • 16

    Kim WJ, Laterza OF, Hock KG, Pierson-Perry JF, Kaminski DM, Mesguich M, et al. Performance of a revised cardiac troponin method that minimizes interferences from heterophilic antibodies. Clin Chem 2002; 48: 1028–34. Google Scholar

  • 17

    Bodor GS, Porter S, Landt Y, Landenson JH. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin Chem 1992; 38: 2201–14. Google Scholar

  • 18

    National Committee for Clinical Laboratory Standards. Evaluation of precision performance of clinical chemistry devices; approved guideline. NCCLS guideline EP5-A. Wayne, PA: NCCLS, February 1999. Google Scholar

  • 19

    Geiger DU, Wu AHB, Apple FS, Jevans AW, Venge P, Olson MD et al. Multicenter evaluation of an automated assay for troponin I. Clin Chem 2002; 48: 869–76. Google Scholar

  • 20

    National Committee for Clinical Laboratory Standards. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; proposed guideline. NCCLS guideline EP6-A. Wayne, PA: NCCLS, September 1986. Google Scholar

  • 21

    National Committee for Clinical Laboratory Standards. Method comparison and bias estimation using patient samples; approved guideline. NCCLS guideline EP9–A. Wayne, PA: NCCLS, December 1995. Google Scholar

  • 22

    Kost GJ. Connectivity, the millennium challenge for point-of-care testing. Arch Pathol Lab Med 2000; 124: 1108–10. Google Scholar

  • 23

    Kaminski D, Sivakoff S, McCormack B, Pierson-Perry J. Development and analytical performance of an improved method for cardiac troponin-I on the Dade Behring Dimension clinical chemistry system. Clin Chem 2001; 47(Suppl): A211. Google Scholar

  • 24

    Martin RF. General Deming regression procedures for methods comparison studies. Clin Chem 1993; 39: 424–32. Google Scholar

  • 25

    Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i: 307–10. CrossrefGoogle Scholar

  • 26

    Di Serio F, Trerotoli P, Serio G, Varraso L, Pansini N. Analytical evaluation of an automated immunoassay for cardiac troponin I: the Vidas troponin I assay. Clin Chem Lab Med 2003; 41: 1363–8. CrossrefGoogle Scholar

  • 27

    Panteghini M, Pagani F, Yeo KJ, Apple FS, Christenson RH, Dati F, et al. Evaluation of imprecision for cardiac troponin assay at low-range concentration. Clin Chem 2004; 50: 327–32. CrossrefGoogle Scholar

  • 28

    Christenson RH, Cervelli DR, Bauer RS, Gordon M. Stratus CS cardiac troponin I method: performance characteristics including imprecision at low concentration. Clin Biochem 2004; 37: 679–83. CrossrefGoogle Scholar

  • 29

    Lamb LS. Responsibilities in point-of-care testing: an institutional perspective. Arch Pathol Lab Med 1995; 119: 886–9. Google Scholar

  • 30

    Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem 2002; 48: 691–8. Google Scholar

  • 31

    Galvani M, Panteghini M, Ottani F, Cappelletti P, Chiarello F, Crea F, et al. “La nuova definizione di infarto miocardico” analisi del documento di consenso ESC/ACC e riflessioni sulla applicabilità alla realtà sanitaria Italiana. Biochim Clin 2002; 26: 21–40. Google Scholar

  • 32

    Lee-Lewandrowski E, Corboy D, Lewandrowski K, Siclair J, McDermot S, Benzer TI. Implementation of a point-of-care satellite laboratory in the emergency department of an academic medical center. impact on test turnaround time and patient emergency department length of stay. Arch Pathol Lab Med 2003; 127: 456–60. Google Scholar

About the article

Corresponding author: Francesca Di Serio, Via Cardinale Mimmi 16, 70124 Bari, Italy Phone: +39-080-5592629/124, Fax: +39-080-5592124,


Received: 2004-11-06

Accepted: 2004-12-10

Published Online: 2011-09-21

Published in Print: 2005-04-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2005.035.

Export Citation

©2005 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Valentina Pecoraro, Giuseppe Banfi, Luca Germagnoli, and Tommaso Trenti
Annals of Clinical Biochemistry, 2017, Volume 54, Number 4, Page 420
[2]
Peter B. Luppa, Andreas Bietenbeck, Christopher Beaudoin, and Ambra Giannetti
Biotechnology Advances, 2016, Volume 34, Number 3, Page 139
[3]
K. Thygesen, J. Mair, E. Giannitsis, C. Mueller, B. Lindahl, S. Blankenberg, K. Huber, M. Plebani, L. M. Biasucci, M. Tubaro, P. Collinson, P. Venge, Y. Hasin, M. Galvani, W. Koenig, C. Hamm, J. S. Alpert, H. Katus, and A. S. Jaffe
European Heart Journal, 2012, Volume 33, Number 18, Page 2252
[4]
Olaf Schulz, Claudia Paul-Walter, Matthias Lehmann, Klaus Abraham, Gunnar Berghöfer, Ingolf Schimke, and Allan S. Jaffe
The American Journal of Cardiology, 2007, Volume 100, Number 5, Page 764
[5]
Francesca Di Serio, Gianfranco Amodio, Enzo Ruggieri, Rosalisa De Sario, Lucia Varraso, Gianfranco Antonelli, and Nicola Pansini
Clinica Chimica Acta, 2005, Volume 357, Number 2, Page 226
[6]
Francesca Di Serio, Maria Antonia Petronelli, and Eugenio Sammartino
Clinical Chemistry and Laboratory Medicine, 2010, Volume 48, Number 7
[7]
Urs E. Nydegger, Erich Gygax, and Thierry Carrel
Clinical Chemistry and Laboratory Medicine (CCLM), 2006, Volume 44, Number 9
[8]
Hugon Možina, Valerija Vukan, Katarina Lenart, Milan Skitek, and Joško Osredkar
Point of Care: The Journal of Near-Patient Testing & Technology, 2010, Volume 9, Number 1, Page 8
[9]
Christopher P. Price
Point of Care: The Journal of Near-Patient Testing & Technology, 2008, Volume 7, Number 4, Page 261
[10]
Francesca Di Serio, Gianfranco Amodio, Lucia Varraso, Vincenzo Ruggieri, Gianfranco Antonelli, and Nicola Pansini
Point of Care: The Journal of Near-Patient Testing & Technology, 2007, Volume 6, Number 3, Page 183
[11]
Gianfranco Amodio, Gianfranco Antonelli, Lucia Varraso, Vincenzo Ruggieri, and Francesca Di Serio
Coronary Artery Disease, 2007, Volume 18, Number 3, Page 181
[12]
Stacy E. F. Melanson
Point of Care: The Journal of Near-Patient Testing & Technology, 2006, Volume 5, Number 2, Page 74
[13]
Patrick M. Sluss
Point of Care: The Journal of Near-Patient Testing & Technology, 2006, Volume 5, Number 1, Page 38

Comments (0)

Please log in or register to comment.
Log in